Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Haematological Malignancies
Interventions
BIOLOGICAL

CD25/71 allodepleted donor T-cells

CD25/71 allodepleted donor T-cells will be administered at a dose of 10\^5 /kg at day 30 post-SCT, 3 x 10\^5 /kg at day 60 and 10\^6 /kg at day 90 post transplant

Trial Locations (2)

Unknown

University College London Hospital, London

Manchester Royal Infirmary, Manchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

University College, London

OTHER